See also this year's filing and all EDGAR filings for this company.
PDF Report 0001652130_2019_Intellia_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001652130, Intellia Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 40,572,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 324,977,000 |
| 4 | AssetsNoncurrent | 5,277,000 |
| 5 | PropertyPlantAndEquipmentNet | 17,061,000 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 32,189,000 |
| 9 | ResearchAndDevelopmentExpense | 89,115,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 30,434,000 |
| 12 | remainder_NetIncome | 5,527,000 |
| 13 | remainder_ComprehensiveNetIncome | -28,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 40,572,000 |
| 1 | Assets | 347,315,000 |
| 2 | Expenses | 121,304,000 |
| 3 | Revenues | 30,434,000 |
| 4 | StockholdersEquity | 306,743,000 |
| 5 | NetIncome | -85,343,000 |
| 6 | ComprehensiveNetIncome | -85,357,000 |
| 7 | BaseVar | 272,590,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.73 |
| 9 | EconomicCapitalRatio | 2.16 |